see treatment	37
reduce the risk	9
see therapies	7
agents/circumstances to	6
see agents/circumstances	5
prevent development	5
% to	4
and to	4
in order to	3
alternatives to	3
exposure to	3
the ability to	3
failure to	3
prevent hypoglycemia	3
prevent attacks	3
halt the progression	3
in addition to	2
months to	2
body temperature to	2
trauma to	2
the need to	2
antibodies to	2
igg antibodies to	2
adherence to	2
every other day to	2
the decision to	2
of some benefit to	2
enough enzyme activity to	2
a low-fat diet to	2
minimize the risk	2
prevent metabolic decompensations	2
undergo hsct	2
assess the severity	2
prevent the onset	2
prevent catabolism	2
reverse symptoms and signs	2
prevent disease manifestations	2
prevent the progression	2
influence decisions	2
correct the metabolic defect	2
improve blood counts	2
be candidates	2
provide protection	2
eliminate spontaneous bleeding and prevent	2
prevent primary disease manifestations	2
be b6 responsive	2
vitamin b12	2
see table	2
start treatment	2
prevent disease recurrences	2
be standard nomenclature	2
prevent the primary manifestations	2
minimize pancreatic stimulation	2
minimize pancreatic exocrine stimulation	2
prevent infection	2
physicians to	1
distributions to	1
patients with aceruloplasminemia to	1
dietary modification to	1
with a failure to	1
important for parents to	1
a sufficient dose to	1
primary failure to	1
decline to	1
ert in order to	1
hypersensitivity reactions to	1
a barrier to	1
asymptomatic with compliance to	1
biotin to	1
and/or fail to	1
a period of weeks to	1
mg per day to	1
prospective data to	1
no evidence to	1
classic 21-ohd cah in order to	1
hospitalization to	1
mg/kg oral solution to	1
ifn-gamma in addition to	1
non-compliant with respect to	1
primary neurologic sequelae to	1
multidisciplinary evaluation to	1
slow-release carbohydrate to	1
intercurrent infections to	1
diet to	1
after diagnosis to	1
sufficient tissue concentration to	1
ten to	1
minimal trauma to	1
shins in order to	1
low-resistance exercise to	1
significant progress to	1
axial stress to	1
years in order to	1
with regard to	1
agalsidase beta to	1
beta with regard to	1
prophylactic anticoagulation during exposure to	1
therapies to	1
affected individuals to	1
no recognized therapies to	1
sufficient exogenous enzyme to	1
influence the response to	1
individuals with mild to	1
clinical trials to	1
platelet count from baseline to	1
mean of -1.6 to	1
ways to	1
molecular genetic testing to	1
a poor clinical response to	1
cardiac mass to	1
a poor response to	1
high igg titers to	1
clinical severity to	1
cornstarch tend to	1
at-risk relatives to	1
the half-life three- to	1
specific ingredients to	1
medical record to	1
practitioners to	1
with exposures to	1
a favorable approach to	1
proximal margins to	1
referral to	1
β-oxidation to	1
avms to	1
the conversion of homocysteine to	1
an alternate remethylation pathway to	1
excess homocysteine to	1
homocysteine to	1
reason to	1
sufficient enzyme activity to	1
soluble fiber to	1
irreversible damage to	1
no effective treatments to	1
prophylactic mastectomy to	1
marfan syndrome to	1
conjunction with a beta-blocker to	1
complex carbohydrates at bedtime to	1
] to	1
age to	1
before progression to	1
surgery to	1
no significant improvement relative to	1
the response to	1
a thorough anesthetic history to	1
some individuals to	1
natural protein to	1
1.0-mg injections every day to	1
propionylcarnitine excretion to	1
antibiotic regimens to	1
week to	1
response to	1
“ cell therapy ” to	1
a safe alternative to	1
years to	1
continue to	1
the degree to	1
access to	1
attenuated disease remain to	1
ability to	1
variable responsiveness to	1
the ability of ert to	1
with respect to	1
inverse correlation to	1
birth to	1
10-40 mg/kg/day to	1
% for the a to	1
on demand to	1
no way to	1
any attempts to	1
the cutaneous response to	1
extra attention to	1
circumstances to	1
no known effective measures to	1
shear forces to	1
studies to	1
individuals with phts to	1
bilateral salpingo-oophorectomy to	1
no therapy to	1
dietary management needs to	1
natural source protein to	1
methylcitric acid to	1
an effective strategy to	1
an important point of intervention to	1
calorie intake to	1
the clinician to	1
phytanic acid to	1
no known therapy to	1
chronic pain refractory to	1
approaches to	1
strong evidence to	1
a careful titration of the drug to	1
the door to	1
providers to	1
weekly phlebotomy to	1
the time of diagnosis to	1
cotrimoxazole prophylaxis to	1
vwf/fviii concentrates to	1
asymptomatic patients to	1
t cells in order to	1
older infants to	1
a reaction to	1
uv-absorbing face shields to	1
individuals to	1
in contrast to	1
antibody production to	1
increased susceptibility to	1
rapid transition to	1
body and to	1
lifestyle and dietary modification to	1
comparable or superior to	1
no allergic or hypersensitivity reactions to	1
important but difficult to	1
manifestations and agents/circumstances to	1
a week or every other day to	1
or every other day to	1
chart or medical record to	1
the hfi diagnosis and to	1
or difficult to	1
telangiectases and avms to	1
pressure and trauma to	1
and exposure to	1
cells and to	1
the skin and the cutaneous response to	1
skin pigmentation and the ability to	1
and shear forces to	1
adequate hydration status and to	1
prophylactic hysterectomy and bilateral salpingo-oophorectomy to	1
and methylcitric acid to	1
acute decompensations and to	1
obesity and the need to	1
weight increase and to	1
families and providers to	1
hypogammaglobulinemia and cotrimoxazole prophylaxis to	1
serious infections or failure to	1
identify affected individuals	1
allow physicians	1
improve the informed decision-making process	1
diminish iron accumulation	1
avoid known triggers	1
reduce the number	1
suppress exercise-induced ventricular arrhythmias	1
reduce cardiac arrhythmias	1
prevent graft loss	1
perform conditioning	1
achieve stable engraftment [ gaspar	1
exist [ cancrini	1
obtain specific information	1
multiple strands	1
reduce immunogenicity	1
injure other organs	1
maintain a non-toxic metabolic environment	1
prevent opportunistic infections and other clinical manifestations	1
receive immunoglobulin replacement	1
recover protective immune function	1
eliminate efficacy	1
undergo bmt/sct	1
undergo the procedure	1
bovine ada and	1
compromise efficacy	1
prevent acute attacks patients	1
exacerbate porphyria	1
have beneficial effects	1
pose a barrier	1
minimize the acidosis	1
undergo gonadectomy	1
estrogen replacement therapy	1
maintain bone health	1
receive lifelong treatment	1
be maintenance	1
maintain protein biosynthetic function	1
be an arginine-free essential amino acid mixture	1
maintain adequate growth	1
achieve this end [ brusilow	1
reverse the abnormalities	1
improve cognitive outcome	1
reverse abnormalities	1
influence the outcome	1
replenish this amino acid	1
reverse the hair changes	1
detect a difference	1
have merits	1
correct the arginine deficiency or elevation	1
predict appropriate icd discharge	1
perform procedure/treatment	1
develop [ amiel	1
reduce risk	1
need treatment	1
develop symptoms	1
biotin therapy	1
administer biotin	1
grow bacteria	1
provide a consistent dose and	1
show delays	1
determine the dosage	1
consider prophylactic bilateral mastectomy	1
consider prophylactic oophorectomy	1
reduce the health hazards	1
require prospective data	1
restore st segment elevation	1
decrease the incidence	1
prevent hypertriglyceridemia	1
identify infants	1
initiate glucocorticoid and mineralocorticoid treatment	1
avoid situations	1
be a routine part	1
mannose normalized hypoproteinemia and coagulation defects	1
have progressive liver fibrosis [ mention	1
administer intravenous glucose	1
tolerate oral intake	1
exert a protective effect	1
be the case	1
sulfonamides include trimethoprim	1
receive either placebo or itraconazole	1
tolerate itraconazole	1
confuse the clinical picture and alter decision	1
risk avoidance	1
require colostomy or colectomy	1
increase the likelihood	1
prevent hyperammonemia and	1
improve growth	1
develop neurologic complications	1
exclude individuals	1
prevent irreversible secondary complications	1
be no significant difference	1
receive prophylactic anticholinesterase therapy	1
use apnea monitors and	1
decrease the risk	1
provide a constant supply	1
recommend a low-fat diet	1
require the carnitine shuttle	1
provide a constant source	1
achieve this effect	1
provide fuel	1
deplete cystinotic cells	1
initiate cysteamine therapy	1
achieve sufficient tissue concentration	1
dissolve corneal crystals	1
prevent clinical manifestations	1
control the onset	1
treat elane-related neutropenia	1
be the preferred treatment option [ choi	1
improve the orthostatic hypotension and symptoms	1
prevent irreversible sequelae	1
cause body temperature	1
return body temperature	1
be the first sign	1
prevent early joint contractures	1
prevent the neurologic dysfunction	1
see msud	1
reduce disease manifestations	1
stabilize channels	1
protect bony prominences	1
reduce trauma	1
reduce blister formation	1
soften hyperkeratosis and	1
ease debridement	1
wear protective pads or bandages	1
avoid skin tears	1
wear soccer pads or ski stockings	1
reduce easy bruising but	1
increase muscle tone	1
muscle strength	1
have potential life-threatening complications	1
reduce the number or severity	1
improve life expectancy [ beck	1
experience any severe clinical events	1
agalsidase alfa	1
be no difference	1
start ert	1
manage dystonia	1
help affected individuals	1
maintain independence	1
appropriate community resources	1
prevent colorectal cancer	1
be an aberration	1
prevent both the inflammatory attacks	1
need 0.5-1 mg/day	1
receive colchicine	1
have the p.met694val pathogenic variant	1
warrant the initiation	1
colchicine treatment	1
anakinra [ hacihamdioglu	1
reduce the duration	1
have a therapeutic advantage	1
colchicine [ belkhir	1
stop the attacks	1
investigate the long-term effects	1
supplement oral colchicine	1
decrease the disease severity	1
colchicine [ tunca	1
demonstrate a definitive effect	1
reverse the metabolic abnormalities	1
alter urinary excretion	1
improve clinical signs	1
take months	1
obtain the results	1
distinguish peripheral epimerase deficiency galactosemia	1
advise dietary restriction	1
see ert	1
overcome the block	1
taliglucerase alfa	1
expose the alpha-mannosyl	1
substrate reduction therapy	1
derive some benefit	1
indicate a poor prognosis [ frei	1
alter ultimate prognosis	1
reach adequate concentrations	1
require assistance	1
restore metabolic homeostasis	1
moderate gaucher disease	1
determine cross-reactive immunologic material	1
produce cross-reactive immunologic material	1
require modified therapy protocols	1
determine the crim status	1
alglucosidase alfa	1
have a poor clinical response	1
provide emergency care	1
have difficulty	1
show sustained improvement	1
be a transient decrease	1
include increase	1
alpha glucosidase	1
have lopd	1
baseline [ bernier	1
improve exercise tolerance	1
require cornstarch	1
promote rhabdomyolysis and muscle cramping	1
trigger an acute attack	1
see clinical description	1
help cpox heterozygotes	1
involve the following	1
treat acute attacks	1
maintain factor viii clotting activity	1
maintain factor ix clotting activity	1
require troughs higher	1
prevent bleeding	1
decrease bleeding and	1
improve joint function and quality	1
avoid include fructose	1
“ no added sugar ”	1
raise suspicion	1
chocolate milk	1
avoid use	1
alert practitioners	1
complete dietary restriction	1
be difficult attain and unrealistic	1
endoscopic surveillance	1
ensure removal	1
undergo ptg	1
consider the following	1
have psychological effects	1
include the possible altered perception	1
control hyperammonemia	1
be a possible association	1
produce phenylacetate	1
develop neurologic complications such	1
correct the hyperammonemia	1
correct tissue-specific metabolic abnormalities	1
prevent associated morbidity and mortality	1
prevent pressure and trauma	1
correct the biochemical abnormalities	1
control the elevated plasma homocysteine concentrations	1
reduce the complications	1
prevent further complications such	1
need revision	1
control total plasma homocysteine concentration	1
be the major form	1
prevent recurrent events	1
require a methionine-restricted diet	1
prevent protein malnutrition	1
be an essential amino acid	1
optimize the conversion	1
decrease the plasma homocysteine concentration	1
convert excess homocysteine	1
see figure	1
prevent complications	1
be any benefit	1
become the major treatment modality	1
attain metabolic control	1
improve general bone health	1
decrease the frequency and intensity	1
evaluate the effect	1
[ ligtenberg et al	1
bumetanide [ wu	1
cross the blood-brain barrier	1
ten weeks	1
stop the progression	1
eculizumab prophylaxis	1
implant an icd	1
reverse anemia [ zivná	1
prevent hyperkalemic attacks	1
target organs such	1
undergo regular phlebotomies	1
prevent the development	1
prevent organ damage	1
possess an expanded cag repeat	1
develop krabbe disease	1
be a risk factor	1
set a lower threshold	1
reduce hemodynamic stress	1
manage volume	1
provide notable protection	1
increase hemodynamic stress	1
manage volume overload	1
ten hours	1
avoid excessive fasting	1
ensure sufficient glucose supply overnight	1
develop the disease	1
prevent thymic carcinoid [ brandi	1
invasive mtc	1
allow surgery	1
determine the response	1
maintain serum copper concentration	1
obtain a thorough anesthetic history	1
determine the possibility	1
be unreliable indicators	1
see differential diagnosis	1
receive succinylcholine	1
receive trigger anesthetics	1
carry proper identification	1
treat the primary central nervous system manifestations	1
undertake the risks	1
slow disease progression	1
see genotype-phenotype correlations	1
have significant cognitive benefits	1
be the aim	1
provide extra fluid and calories	1
produce a nutritional deficiency state	1
affect long-term growth and	1
propiogenic amino-acid deficient formula	1
replace the free carnitine pool	1
enhance the conjugation and excretion	1
be the mechanism	1
reduce the production	1
ten days	1
reduce the propionate load	1
pose a serious infectious threat and	1
be glutathione deficient	1
ascorbate therapy [ treacy	1
prevent progression	1
attenuate the progression	1
allow better comparisons	1
inform decisions	1
contribute enough enzyme activity	1
avert metabolic decompensation	1
et al	1
have progressive renal failure	1
provide enough enzyme activity	1
normalize methylmalonic acid excretion	1
stabilize individuals	1
liver transplantation or liver-kidney transplantation	1
control complement activation and prevent esrd [ licht	1
be possible [ aldenhoven et	1
be significant predictors	1
maximize benefit	1
[ eisengart	1
slow the course	1
show correction	1
ameliorate cardiac valvular or skeletal manifestations	1
have severe mps	1
show significant effects	1
maintain function and gait	1
cross the blood-brain barrier and	1
influence the cns disease	1
perform daily functions	1
reverse disease symptoms	1
adverse immune reactions	1
later administration	1
confirm this finding	1
enter cells and	1
maintain a plasma leucine-to-valine concentration ratio	1
plasma leucine concentration	1
standard psychostimulant and antidepressant medications	1
calorie intake	1
reverse cognitive disability or psychiatric illness	1
arrest progression	1
aminoglycoside treatment	1
have hearing loss	1
avoid a preventable cause	1
identify a preventable form	1
prevent gingival bleeding	1
prevent episodes	1
prevent primary manifestations	1
prevent systemic sequelae	1
perform hsct	1
ten minutes	1
teach parents	1
alter the clinical features	1
prevent a hyperammonemic crisis and coma	1
be an important preventive measure	1
stop drinking	1
delay worsening	1
increase quality	1
reduce the frequency	1
develop esrd	1
reduce symptoms	1
evaluate the optimal dose	1
have exacerbations	1
prevent such an exacerbation	1
enhance intellectual development	1
be optimal [ baxter	1
pyridoxine deficient	1
increase blood viscosity	1
take precautions	1
be the primary therapy	1
maintain adequate hydration status	1
enhance calcium oxalate solubility	1
consider prophylactic mastectomy	1
discuss the limitations	1
prevent gynecologic malignancy	1
prevent frequent noncyclical attacks	1
control the intake	1
intake depends	1
adjust nutritional management	1
facilitate the administration	1
improve adherence	1
be an important point	1
maximize favorable clinical outcomes	1
consider the presence	1
reduce propionic acid production	1
include standard amino acid mixes	1
experience frequent metabolic decompensations	1
ensure adequate hydration and caloric management	1
facilitate appropriate emergency care	1
begin anticipatory guidance	1
monitor weight increase and	1
restrict calories	1
retard obesity and the high proportion	1
improve motor milestones	1
avoid the consequences	1
benefit individuals	1
avoid mobilization	1
contain phytanic acid	1
provide symptomatic relief	1
show some benefits	1
minimize morbidity and mortality	1
maintain the percentage	1
limit alloimmunization and transfusion reactions	1
decrease alloimmunization rates	1
decrease alloimmunization	1
type cells	1
balance the benefits	1
find a dosing	1
decrease the frequency	1
subvert a life	1
discuss the risks and benefits	1
halts the progression	1
deplete iron stores	1
prevent manifestations	1
severe hypogammaglobulinemia and cotrimoxazole prophylaxis	1
prevent pneumocystis jirovecii infection	1
prevent musculoskeletal bleeding and subsequent joint damage	1
generate protective levels	1
recommend splenectomy [ conley	1
take antibiotics	1
employ agents	1
improve unrelated donor graft outcomes	1
cord blood hematopoietic stem cells	1
be a significant problem	1
make adequate antibodies	1
engraft hematopoietic stem cells	1
develop allogeneic	1
discontinue gamma-globulin replacement therapy	1
pneumocystis jiroveci	1
generate antibodies	1
encapsulated bacteria	1
preclude the need	1
prompt immediate sun-protective measures	1
protect all body surfaces	1
permit visibility outdoors	1
measure uv light	1
alert individuals	1
have myeloid engraftment but	1
show evidence	1
reconstitute the humoral immune compartment	1
